Post-Conference CNS Vector Innovation Day

Thursday, December 8 | 9am-2.30pm

9:00 am Morning Coffee & Networking

OPTIMIZING VECTORS FOR CNS TROPISM & SELECTIVITY

9:30 am Introduction: Evaluating the Gene Therapy Vectors Currently Available for Neurological Disorders

  • Ben Deverman Director of Vector Engineering, Stanley Center for Psychiatric Research, Broad Institute

10:00 am The Power of Naturally Occurring AAV Capsids for the Development of Gene Transfer & Gene Editing Therapies

  • Laura Jane Smith Principle Scientist & Scientific Co-founder, Homology Medicines

10:30 am Short Break

11:00 am Engineering CNS-targeted AAV Capsids from Massively Diverse Libraries Using Machine Learning

11:30 am In Vivo Evaluation of Novel Synthetic Promoters for CNS Gene Therapy

Synopsis

Session Reserved

12:00 pm Lunch & Roundtable Discussion

1:30 pm Capsid Engineering for Systemic AAV Gene Therapy for CNS Targets

Synopsis

2:00 pm Panel: The Future of CNS Vectors

2:30 pm End of Post-Conference CNS Vector Innovation Day